Peter Dedeken
Impact in
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
Papers in
-
- Epilepsy research and treatment 31
-
- Pharmacological Effects and Toxicity Studies 3
- Co-authors
- Dirk E. Teuwen (13 shared papers)Paul Boon (13 shared papers)Azita Tofighy (3 shared papers)Simon Borghs (7 shared papers)Marc De Backer (8 shared papers)Frank Tennigkeit (5 shared papers)Stephan Vlaminck (1 shared paper)Ludo J. Vanopdenbosch (1 shared paper)
In The Last Decade
Peter Dedeken
36 papers receiving 703 citations
Peers
Comparison fields: 5 of 75
- Psychiatry and Mental health 465
- Clinical Biochemistry 74
- Neurology 86
- Endocrinology, Diabetes and Metabolism 64
- Rheumatology 45
Countries citing papers authored by Peter Dedeken
This map shows the geographic impact of Peter Dedeken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Dedeken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Dedeken more than expected).
Fields of papers citing papers by Peter Dedeken
This network shows the impact of papers produced by Peter Dedeken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Dedeken. The network helps show where Peter Dedeken may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Dedeken, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 274 | |
| 2 | 2015 | 54 | |
| 3 | 2015 | 48 | |
| 4 | 2015 | 37 | |
| 5 | 2014 | 33 | |
| 6 | 2010 | 30 | |
| 7 | 2016 | 26 | |
| 8 | 2018 | 26 | |
| 9 | 2019 | 22 | |
| 10 | 2020 | 21 | |
| 11 | 2017 | 18 | |
| 12 | 2016 | 15 | |
| 13 | DRUG UTILIZATION STUDY WITH LACOSAMIDE IN DAILY CLINICAL PRACTICE IN BELGIUM: AN INTERIM ANALYSIS | 2012 | 13 |
| 14 | 2016 | 10 | |
| 15 | 2020 | 10 | |
| 16 | 2012 | 9 | |
| 17 | 2019 | 8 | |
| 18 | 2021 | 8 | |
| 19 | 2017 | 7 | |
| 20 | 2019 | 7 |
About Peter Dedeken
Peter Dedeken is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Rheumatology, Health, Toxicology and Mutagenesis and Management Science and Operations Research, having authored 37 papers that have together received 729 indexed citations. Recurring topics across this work include Epilepsy research and treatment (31 papers), Pharmacological Effects and Toxicity Studies (3 papers), Heavy Metal Exposure and Toxicity (2 papers), Psychometric Methodologies and Testing (2 papers), Glycogen Storage Diseases and Myoclonus (2 papers), Health Education and Validation (2 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Psychiatry and Mental health (465 citations), Clinical Biochemistry (74 citations), Neurology (86 citations), Endocrinology, Diabetes and Metabolism (64 citations) and Rheumatology (45 citations). Peter Dedeken has collaborated with scholars based in Belgium, Germany and Rwanda. Frequent co-authors include Dirk E. Teuwen, Paul Boon, Azita Tofighy, Simon Borghs, Marc De Backer, Frank Tennigkeit, Stephan Vlaminck, Ludo J. Vanopdenbosch, Jacques Casselman and Matthias Noack‐Rink. Their work appears in journals such as Epilepsy & Behavior, Neurology, Epilepsia Open, Acta Neurologica Scandinavica and Journal of General Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.